.svg)
Solt DB is a biotech equities research firm. The finch helps investors understand the science behind their investments and helps scientists understand the business of biotech.
Founded as a public benefit company, Solt DB uses an engaging writing style and data visualizations to explain nerdy topics in the bioeconomy. We generate 100% of revenue from memberships to investment research. Our unique business model means you'll never be interrupted by ads, clickbait, or corporate sponsors – even if you never become a paying member. That also means the finch is fiercly independent. We routinely hold bad actors accountable with fair, objective reporting. We're not afraid to stake out new arguments that go against herd thinking. And we always stand up for the little guy.
Members have access to a comprehensive biotech investing approach spanning expert research, financial modeling, and portfolio frameworks. We demonstrate our approach with a long-term, real-money portfolio called Finch Trades. By transparently showing every transaction and position build out – and measuring the performance of every invested dollar against four passive investing benchmarks – members see how a successful biotech investing strategy can be implemented in the messy real world.
We don't tell you about biotech. We show you.
Solt DB creates interactive data visualizations to discuss and analyze living technology in vivid detail. From individual company insights to broad trends across competitive landscapes, the finch helps you objectively understand the bioeconomy – even when trends don't match the headlines.
Click or hover these charts to view data labels.
Solt DB uses the same illustration tools as scientists publishing in the world's top journals -- a first in finance.
The combination of simple language and clear visuals allows investors of all backgrounds to more deeply understand the biotech stocks they own, while scientists can gain a better grasp of the business of biotech.
.svg)
.svg)
.svg)
.svg)
-cropped.svg){kind=small}